The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: Journal of Medical Economics, Vol. 14, No. 1, 17.01.2011, p. 130-9.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - The economic burden of advanced Parkinson’s disease
T2 - an analysis of a UK patient dataset
AU - Findley, Leslie J
AU - Wood, Eifiona
AU - Lowin, Julia
AU - Roeder, Claudia
AU - Bergman, Annika
AU - Schifflers, Mathias
PY - 2011/1/17
Y1 - 2011/1/17
N2 - BACKGROUND: To evaluate the cost burden of patients with advanced Parkinson's disease (PD) according to the waking hours per day spent in OFF state. An analysis of resource use comprising medical services, professional care and informal care data from an observational, cross-sectional study was conducted.METHODS: A total of 60 physicians comprising 40 neurologists and 20 geriatricians across the UK participating in the Adelphi PD Disease Specific Programme took part. There were 302 PD patients at H&Y stages 3-5. Patients were characterised according to the percentage of time per day spent in OFF state (<25%, 26-50%, 51-75%, >75%).RESULTS: Average 12-monthly total costs increased according to the time spent in OFF state from £25,630 in patients spending less than 25% of their waking hours in OFF to £62,147 for patients spending more than 75% of their time in OFF. Overall, 7% of costs were attributed to direct medical care, while 93% were split between direct non-medical professional care (50%) and indirect informal care (43%).LIMITATIONS: Low patient numbers in the more advanced disease stages of PD led to very little or no data to directly inform some of the severe health states of the analysis. Data gaps were filled in with data derived from a regression analysis which may affect the robustness of the analysis.CONCLUSION: This study illustrates the increasing costs of advancing PD, in particular related to the time spent in OFF state, and identifies that the foremost cost burden is associated with the care needs of the patient rather than medical services.
AB - BACKGROUND: To evaluate the cost burden of patients with advanced Parkinson's disease (PD) according to the waking hours per day spent in OFF state. An analysis of resource use comprising medical services, professional care and informal care data from an observational, cross-sectional study was conducted.METHODS: A total of 60 physicians comprising 40 neurologists and 20 geriatricians across the UK participating in the Adelphi PD Disease Specific Programme took part. There were 302 PD patients at H&Y stages 3-5. Patients were characterised according to the percentage of time per day spent in OFF state (<25%, 26-50%, 51-75%, >75%).RESULTS: Average 12-monthly total costs increased according to the time spent in OFF state from £25,630 in patients spending less than 25% of their waking hours in OFF to £62,147 for patients spending more than 75% of their time in OFF. Overall, 7% of costs were attributed to direct medical care, while 93% were split between direct non-medical professional care (50%) and indirect informal care (43%).LIMITATIONS: Low patient numbers in the more advanced disease stages of PD led to very little or no data to directly inform some of the severe health states of the analysis. Data gaps were filled in with data derived from a regression analysis which may affect the robustness of the analysis.CONCLUSION: This study illustrates the increasing costs of advancing PD, in particular related to the time spent in OFF state, and identifies that the foremost cost burden is associated with the care needs of the patient rather than medical services.
KW - Aged
KW - Cost of Illness
KW - Costs and Cost Analysis
KW - Cross-Sectional Studies
KW - Female
KW - Health Services/economics
KW - Humans
KW - Male
KW - Parkinson Disease/economics
KW - Severity of Illness Index
KW - United Kingdom
U2 - 10.3111/13696998.2010.551164
DO - 10.3111/13696998.2010.551164
M3 - Article
C2 - 21235405
VL - 14
SP - 130
EP - 139
JO - Journal of Medical Economics
JF - Journal of Medical Economics
SN - 1369-6998
IS - 1
ER -